Add BrightSurf on Google Email

Cost-savings of colorectal cancer screening as treatment costs increase

A new study found that investing in colorectal cancer screening programs could reduce treatment costs by more than half. The study suggests that the increasing use of expensive cancer drugs will make screening programs more cost-effective, making them a desirable investment for governments and insurance companies.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateSep 24, 2009

JCI online early table of contents: Aug. 3, 2009

Researchers at Children's Hospital of Philadelphia have identified an immune mechanism responsible for graft failure in a mouse model of IUHCT. Maternal alloantibodies, produced in response to IUHCT, trigger a postnatal immune response that limits engraftment following in utero hematopoietic cell transplantation. This finding opens the...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 3, 2009

Cost-effective strategy to screen second primary colorectal cancers in cancer survivors

A decision-analytic model suggests that more frequent and strict colonoscopy recommendations can be cost-effective strategies for screening second primary colorectal cancers in male cancer survivors. The most vulnerable population aged 40 years old may benefit from COL5, while the general population aged 50 years old may follow COL10.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateJul 16, 2009

News from Cancer

Researchers found that ultrasound outperforms symptom analysis in detecting ovarian cancer, with TVS performing better for malignancies. Racial disparities in colorectal cancer survival dissipate after adjusting for demographic and clinical factors. Thyroid cancer incidence increases across all tumor sizes, suggesting screening is not ...

SourceAmerican Cancer Society·JournalCancer·DateJul 13, 2009

Colorectal cancer

Researchers at Max Delbrück Center for Molecular Medicine have identified 115 genes associated with metastatic potential in colorectal cancer. The study found that BAMBI gene is more active in metastatic tumors, promoting metastasis formation through key signaling pathways.

SourceHelmholtz Association·JournalGASTROENTEROLOGY·DateJul 1, 2009

Risk of cancer

Researchers identified a novel mechanism linking a common single-base variant in chromosome 8 to an increased risk of colorectal cancer. This variant is carried by nearly all African populations and contributes significantly to the disease at a population level, yet its impact on individual susceptibility is minimal.

SourceAcademy of Finland·JournalNature Genetics·DateJun 29, 2009

Study finds people residing in poor communities not benefiting from recent drop in colorectal cancer

A recent study found that colorectal cancer incidence rates decreased significantly among whites aged 65 and over, but not among those in poorer communities. The researchers suggest that lack of access to healthcare may be the reason for this disparity. Colorectal endoscopic screening rates also increased among whites, but were lower a...

SourceAmerican Cancer Society·JournalCancer Causes & Control·DateJun 24, 2009

New piece found in colorectal cancer puzzle

Researchers found increased mRNA levels of PN-1, a prostasin inhibitor, in colorectal tissue samples from patients with mild/moderate dysplasia and severe dysplasia before colorectal cancer. Elevated PN-1 levels coincide with the acquisition of malignant properties in colorectal tissue.

SourceBMC (BioMed Central)·JournalBMC Cancer·DateJun 24, 2009

Advances in liver surgery enable the prospect of curative treatment for more patients

A study published in World Journal of Gastroenterology found that patients with extrahepatic disease, high carcinoembriogenic antigen levels, or multiple nodules have poorer survival rates. Despite this, advances in surgical technique and complementary treatments are increasing the number of patients benefiting from curative treatment.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateJun 12, 2009

Advance in bowel cancer test research

Australian researchers have developed gene expression biomarkers that can accurately detect pre-cancerous and cancerous colorectal growths from non-cancerous controls. This breakthrough is a result of a collaborative study involving CSIRO, Flinders University, and Clinical Genomics Pty Ltd.

M. D. Anderson study finds dramatic increase in metastatic colon cancer survival

Researchers at M.D. Anderson Cancer Center found a significant increase in median overall survival from 8 to 30 months for patients with advanced disease, and a projected five-year survival rate of over 30 percent. The study attributes the improvements to better surgical interventions and new chemotherapeutic agents.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalJournal of Clinical Oncology·DateMay 26, 2009

A novel marker of colorectal carcinoma

A novel marker of TSPAN1 has been identified as a significant prognostic indicator for patients with colorectal adenocarcinoma. The protein's expression was found to correlate with histological grade, cell proliferation, lymph nodal metastasis, and TNM staging, leading to a shorter survival period in those with overexpression.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateMay 22, 2009

Colorectal cancer risks quantified

Researchers analyzed primary care records of 5,477 colorectal cancer patients and 38,314 controls to quantify the exact risks posed by eight clinical features. The study found that rectal bleeding carries a high risk warranting investigation regardless of other symptoms.

SourceBMC (BioMed Central)·JournalBMC Medicine·DateApr 16, 2009

Health benefits, consequences of folic acid dependent on circumstances

Research suggests that folate intake can have dual positive and negative effects, with adequate intake offering protection against cancer but excessive amounts facilitating tumor growth. The optimal level of folate intake varies depending on the individual's specific circumstances, highlighting the need for tailored guidelines.

SourceWiley·JournalNutrition Reviews·DateApr 1, 2009

Water method for unsedated colonoscopy; interval between prep and colonoscopy predicts prep quality

Researchers found that using a novel water method for unsedated colonoscopy improved cecal intubation rates and patient willingness to repeat the procedure. The study also revealed that the duration of the interval between bowel preparation completion and colonoscopy start time predicts prep quality.

SourceAmerican Society for Gastrointestinal Endoscopy·JournalGastrointestinal Endoscopy·DateMar 2, 2009

Also in the Feb. 24 JNCI

Researchers found that gene expression profiles differed between tumor samples from patients who had taken vitamin E, selenium, or both supplements compared to those on placebo. The study provides insight into the effects of preoperative supplement use on prostate cancer gene expression, a potential area for future investigation.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateFeb 24, 2009

Calcium associated with lower risk of cancer in women

Women with higher calcium intake have a lower risk of cancer overall and specific digestive system cancers like colorectal cancer, according to the study. Calcium consumption was inversely associated with an increased risk of these types of cancers in both men and women.

SourceJAMA Network·JournalArchives of Internal Medicine·DateFeb 23, 2009

Mail and electronic reminders may increase colon cancer screening

A study published in Archives of Internal Medicine found that mail reminders increased colon cancer screening rates by 44% compared to non-reminded patients. Electronic physician reminders also showed promise, especially among patients with three or more primary care visits, resulting in a 59.5% screening rate.

SourceJAMA Network·JournalArchives of Internal Medicine·DateFeb 23, 2009